Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

90.95 +2.88 (+3.27%)
Streaming Delayed Price Updated: 2:15 PM EST, Jan 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
22 23 Next >
News headline image
5 Things to Know in Investing This Week ↗
The Shockwave Issue 
Via Benzinga
News headline image
Looking Into Boston Scientific's Recent Short Interest ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today ↗
 
Via Benzinga
News headline image
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst ↗
Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential... 
Via Benzinga
News headline image
NYSE:BSX may be ready to breakout. ↗
Will BOSTON SCIENTIFIC CORP breakout? 
Via Chartmill
News headline image
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today ↗
 
Via Benzinga
News headline image
17 Analysts Have This To Say About Boston Scientific ↗
 
Via Benzinga
News headline image
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today ↗
 
Via Benzinga
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
A look at five stocks that are seeing increased attention from investors and Benzinga readers. The list includes several large cap stocks for the week. 
Via Benzinga
News headline image
Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst ↗
Fellow infant formula maker Reckitt Benckiser was ordered to pay $60 million to a mother whose baby died after eating Enfamil. 
Via Investor's Business Daily
Topics Death
News headline image
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher ↗
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
News headline image
The Hot List: 3 AI Stocks Worth Buying on Weakness ↗
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect ↗
Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks. 
Via Benzinga
News headline image
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Boston Scientific Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Citadel Is The Most Successful Hedge Fund In History: Here Are Its Top Investment Picks ↗
 
Via Benzinga
News headline image
Stock Market Handles Huge Earnings Week, Fed's Powell, Jobs Report: Weekly Review ↗
The Dow led the major indexes higher. Big techs diverged on results. 
Via Investor's Business Daily
Topics Economy Stocks
Boston Scientific Corp. (NYSE: BSX) Sets New 52-Week High in Friday Session
Via Investor Brand Network
News headline image
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years ↗
 
Via Benzinga
News headline image
Key Takeaways From Boston Scientific Analyst Ratings ↗
 
Via Benzinga
News headline image
Stryker Stock Sees Relative Strength Rating Jump To 84 ↗
The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84. 
Via Investor's Business Daily
News headline image
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Biotech And Medtech Portfolio Notes On A Fed Day ↗
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
News headline image
Nasdaq, S&P 500 Slip Ahead Of Fed Meeting, Regional Banks Sink After NYCB Disappoints: What's Driving Markets Wednesday? ↗
Nasdaq down 1.4%, S&P 500 down 0.9%, Dow up: Volatile day on Wall Street as tech stocks react to disappointing earnings ahead of Fed meeting. 
Via Benzinga
Topics Economy Stocks
News headline image
Why Medical Devices Giant Boston Scientific Shares Are Rising Today ↗
Boston Scientific shares surge in premarket trading following strong Q4 results, beating revenue estimates, amid positive outlook for 2024. 
Via Benzinga
News headline image
Boston Scientific Surges On Its 'Impressive' First-Quarter Guidance ↗
The company expects sales to grow 7% to 9% organically, above expectations. 
Via Investor's Business Daily
News headline image
Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts ↗
Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts. 
Via Investor's Business Daily
Topics Earnings
News headline image
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser ↗
The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook. 
Via Benzinga
Topics Economy
News headline image
Earnings Scheduled For January 31, 2024 ↗
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.